Log In
CQMS
Make a Donation
Log In
Donate
Donate
TROG 2026 ASM: Register now to join us in Melbourne in March
How TROG's Emerging Investigators group is supporting new researchers
2026 Clinical Research Education Workshop (CREW) - Virtual attendance now available
Apply for free virtual CREW places for rural, regional & remote participants .
Notice of AGM of the Trans Tasman Radiation Oncology Group .

TROG 94.01/AGITG IG9401 – Oesophagus – Localised Resectable (IG9401)

Completed
Gastrointestinal

A Randomised Phase III Clinical Trial Comparing Surgery Alone with Concurrent Preoperative Chemotherapy and Radiation Followed by Surgery For Localised Resectable Carcinoma of the Oesophagus

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australasian Gastro-Intestinal Cancer Trials Group (AGITG)

Prev Post

TROG 95.01 – Rectal Cancer

Next Post

TROG 92.01 – PCNSL (Phase II)

Related Post

Roland Towning, participant in TROG NINJA trial
3 February, 2026

Roland’s story

Roland TowningPort Stephens, NSW Roland Towning is taking part

27 January, 2026

New guidelines developed by TROG for clinical trial use of stereotactic radiosurgery for brain metastases

LATEST NEWS: 27 January 2026 New guidelines to ensure